The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections
Carregando...
Fontes externas
Fontes externas
Data
Autores
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Bentham Science Publ Ltd
Bentham Science Publishers
Bentham Science Publishers
Tipo
Resenha
Direito de acesso
Acesso restrito
Fontes externas
Fontes externas
Resumo
Periodontal disease initiation and progression occurs as a consequence of the host immune inflammatory response to oral pathogens. The innate and acquired immune systems are critical for the proper immune response. LPS, an outer membrane constituent of periodontal pathogenic bacteria, stimulates the production of inflammatory cytokines IL-1 beta TNF alpha IL-6 and RANKL either directly or indirectly. In LPS-stimulated cells, the induction of cytokine expression requires activation of several signaling pathways including the p38 MAPK pathway. This review will discuss the significance of the p38 MAPK pathway in periodontal disease progression and the potential therapeutic consequences of pharmacological antagonism of this pathway in the treatment of periodontal diseases.
Descrição
Palavras-chave
Idioma
Inglês
Citação
Current Drug Metabolism. Sharjah: Bentham Science Publ Ltd, v. 10, n. 1, p. 55-67, 2009.
